Broad-spectrum Rapid Antidote: Varespladib IV to Oral Trial for Snakebite (BRAVIO)

Clinical trial NCT05717062 · COMPLETED

Trial details

NCT number: NCT05717062
Sponsor: Ophirex, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Snakebite Envenoming, Snake

Start date: 2023-05-30
Primary completion: 2024-11-28
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.